VACSERA

The Holding Company for Biological Products and Vaccines (VACSERA) started operating a new plant for sera and sterile filling at its subsidiary Egivac, built with investments of EGP 700 million. The plant has a capacity of 8.64 million ampoules and 4.32 million vials per month, producing 13 types of sera and vaccines.